Mitochondrial control of cell death

Nature Medicine

Volumn 6, Issue 5, 2000, Pages 513-519

  Kroemer, Guido ^a   Reed, John C ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; VOLTAGE GATED CHANNEL FORMING PROTEIN;

APOPTOSIS; CELL MEMBRANE PERMEABILITY; CHANNEL GATING; DEGENERATIVE DISEASE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; DISEASE; INTRACELLULAR MEMBRANES; MITOCHONDRIA; MODELS, BIOLOGICAL; PERMEABILITY;

EID: 0034068601     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/74994     Document Type: Review

References (81)

1. Kroemer, C., Dallaporta, B. & Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642 (1998).
2. Green, D.R. & Reed, J.C. Mitochondria and apoptosis. Science 281, 1309-1312 (1998).
3. Cross, A., McDonnell, J.M. & Korsmeyer, S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1988-1911 (1999).
4. Vander Heiden, M.G. & Thompson, C.B. Bcl-2 proteins: Inhibitors of apoptosis or regulators of mitochondrial homeostasis? Nature Cell Biol. 1, E209-E216 (1999).
5. Susin, S.A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999).
6. Heiskanen, K.M., Bhat, M.B., Wang, H.W., Ma, J.J. & Nieminen, A.L. Mitochondrial depopolarization accompanies cytochrome c release during apoptosis in PC6 cells. J. Biol. Chem. 274, 5654-5658 (1999).
7. Kwong, J., Choi, H.L., Huang, Y. & Chan, F.L. Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res. 298, 123-136 (1999).
8. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V. & Di Lisa, F. Mitochondria and cell death - Mechanistic aspects and methodological issues. Eur. J. Biochem. 264, 687-701 (1999).
9. Lemasters, J.J. et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196 (1998).
10. Jürgensmeier, J.M. et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997-5002 (1998).
11. Marzo, I. et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027-2031 (1998).
12. Narita, M. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 14681-14686 (1998).
13. Desagher, S. et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901 (1999).
14. Pastorino, J.G. et al. Functional consequences of sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274, 31734-31739 (1999).
15. Griffiths, G.J. et al. Cell damage-induced conformational changes of the proapoptotic protein bak in vivo precede the onset of apoptosis. J. Cell Biol. 144, 903-914 (1999).
16. Nomura, M. et al. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res 59, 5542-5548 (1999).
17. Khaled, A.R., Kim, K., Hofmeister, R., Muegge, K. & Durum, S.K. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA 96, 14476-14481 (1999).
18. Puthalalath, G., Huang, D.C.S., O'Reilly, L.A., King, S.M. & Strasser, A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287-296 (1999).
19. Harada, H. et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413-422 (1999).
20. Wang, H.G. et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of Bad. Science 284, 339-343 (1999).
21. Yin, X.-M. et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891 (1999).
22. Kirsch, D.G. et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274, 21155-21161 (1999).
23. Kharbanda, S. et al. Translocation of SAPK/JNK to mitochondria and interaction with Bel-XL in response to DNA damage. J. Biol. Chem. 275, 322-327 (2000).
24. Crompton, M. The mitochondrial permeability transition pore and its role in cell death Biochem, J. 341, 233-249 (1999).
25. Szalai, G., Krischnamurthy, R. & Hajnoczky, G. Apoptosis driven by IP3-linked mitochondrial calcium signals EMBO J. 18, 6349-6361 (1999).
26. Ruvolo, P.R., Deng, X., Ito, T., Carr, B.K. & May, W.S. Ceramide induces Bcl-2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274, 20296-20300 (1999).
27. Scorrano, L., Petronilli, V., Di Lisa, F. & Bernardi, P. Commitment to apoptosis by CD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274, 22581-22585 (1999).
28. Wallace, D.C. Mitochondrial diseases in mouse and man. Science 283, 1482-1488 (1999).
29. Ghafourifar, P., Schenk, U., Klein, S.D. & Richter, C. Mitochondrial nitrix-oxide synthase stimulation causes cytochrome c release from isolated mitochondrai -Evidence for intramitochondrial peroxynitrite formation. J. Biol. Chem. 274, 31185-31188 (1999).
30. Van der Heiden, M., Chandel, N.S., Schumacker, P.T. & Thompson, C.B. Bcl-XL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell 3, 159-167 (1999).
31. Brenner, C. et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19, 329-336 (2000).
32. Goldmacher, V.S. et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96, 12536-12541 (1999).
33. Jacotot, E. et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191, 33-45 (2000).
34. Shimizu, S., Narita, M. & Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487 (1999).
35. Eskes, R. et al. Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol. 143, 217-224 (1998).
36. Eskes, R., Desagher, S., Antonsson, B. & Martinou, J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929-935 (2000).
37. Marzo, I. et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J. Exp. Med. 187, 1261-1271 (1998).
38. Andreyev, A. & Fiskum, G. Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death Differ 6, 825-832 (1999).
39. Susin, S.A. et al. Mitochondrial release of caspases-2 and -9 during the apoptotic process. J. Exp. Med. 189, 381-394 (1999).
40. Krajewski, S. et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 5752-5757 (1999).
41. Budijardjo, I., Oliver, H., Lutter, M., Luo, X. & Wang, X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290 (1999).
42. Scaffidi, C., Kirchhoff, S., Krammer, P.H. & Peter, M.E. Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11, 277-285 (1999).
43. Patterson, S. et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ. 7, 137-144 (2000).
44. Khaspekov, L., Friberg, H., Halestrap, A., Viktorov, I. & Wieloch, T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur. J. Neurosci. 11, 3194-3198 (1999).
45. Halestrup, A.P., Kerr, P.M., Javadov, S. & Woodfield, K.-Y. Elucidating the molecular mechanism of the permeability transition and its role in reperfusion injury of the heart. Biochim. Biohys. Acta 1366, 79-94 (1998).
46. LeDucq, N. et al. Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A. Biochem. J. 336, 501 -506 (1998).
47. Yoshimoto, T. & Siesjo, B.K. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 839, 283-291 (1999).
48. Ferrand Drake, M., Friberg, H. & Wieloch, T. Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia. Neuroscience 90, 1325-1338 (1999).
49. Okonkwo, D.O., Buki, A., Siman, R. & Povlishock, J.T. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10, 353-358 (1999).
50. Holmuhamedov, E.L., Wang, L.W. & Terzic, A. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J. Physiol. (London) 519, 347-360 (1999).
51. Cassarino, D.S., Pars, J.K., Parker, W.D. & Bennett, J.P. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolted mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453, 49-62 (1999).
52. Berman, S.B. & Hastings, T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implication for Parkinson's disease. J. Neurochem. 73, 1127-1137 (1999).
53. Rodrigues, C.M.P. et al. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane permeabilization and channel formation. Cell Death Differ. 6, 842-854 (1999).
54. Rodrigues, C.M.P., Fan, G.S., Ma, X.M., Kren, B.T. & Steer, C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101, 2790-2799 (1998).
55. Tabouy, L. et al. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci. 63, 2259-2270 (1998).
56. Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, C. & Attardi, G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286, 774-779 (1999).
57. Koutnikova, H. et al. Studies of human, mouse, and yeast homologues indicate a mitochondrial function for frataxin. Nature Gen. 16, 345-351 (1997).
58. Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973-983 (1998).
59. Sawa, A. et al. Increased apoptosis of Huntingon disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nature Med. 5, 1194-1198 (1999).
60. Fontaine, E., Ichas, F. & Bernardi, P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273, 25734-25740 (1998).
61. Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M. & Przedborski, S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559-562 (1997).
62. Matthews, R.T., Yang, L.C., Browne, S., Baik, M. & Beal, M.F. Coenzyme Q(10) administration increase brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. USA 95, 8892-8897 (1998).
63. Klivenyi, P. et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med. 5, 347-350 (1999).
64. Barrath, P., Albert-Fournier, B., Luciakova, K. & Nelson, B.D. Characterization of a silencer element and purification of a silencer protein that negatively regulates the human adenine nucleotide translocator 2 promoter. J. Biol. Chem. 274, 3378-3384 (1999).
65. Bauer, M.K.A., Schubert, A., Rocks, O. & Grimm, S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell Biol. 147, 1493-1501 (1999).
66. Katabi, M.M., Chan, H.L.B, Karp, S. & Batist, C. Hexokinase type II: A novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Hum. Gene Ther. 10, 155-164 (1999).
67. Habano, W., Sugai, T., Yoshida, T. & Nakamura, S. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int. J. Cancer 83, 625-629 (1999).
68. Joshi, B. et al. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res. 59, 4343-4355 (1999).
69. Fulda, S. et al. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273, 33942-33948 (1998).
70. Ravagnan, L. et al. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 18, 2537-2546 (1999).
71. Marchetti, P. et al. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res. 54, 6257-6275 (1999).
72. Carthy, C.M. et al. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-XL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab. Invest. 79, 953-965 (1999).
73. Miccoli, L. et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res. 58, 5777-5786 (1998).
74. Ellerby, H.M. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nature Med. 5, 1032-1038 (1999).
75. Holinger, E.P., Chittenden, T. & Lutz, R.J. Bak BH3 peptides antagonize Bel-XL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274, 13298-13304 (1999).
76. Cooper, J.M. & Schapira, A.H.V. Mitochondrial dysfunction in neurodegeneration. J. Bioenerg. Biomembr. 29, 175-183 (1997).
77. Carri, M.T. et al. Expression of Cu, Zn Superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414, 365-368 (1997).
78. Sheehan, J.P. et al. Altered calcium homeostasis in cell transformed by mitochondria from individuals with Parkinson disease. J. Neurochem. 68, 1221-1233 (1997).
79. Cassarino, D.S., Swerdlow, R.H., Parks, J.K., Parker, W.D. & Bennett, J.P. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Comm. 248, 168-173 (1998).
80. Guo, Q., Fu, W.M., Holtsberg, F.W., Steiner, S.M. & Mattson, M.P. Superoxide mediates the cell-death-enhancing action of presenilin-1 mutations. J. Neurosci. Res. 56, 457-470 (1999).
81. Passer, B.J., Pellegrini, L., Vito, P., Ganjei, J.K. & D'Adamio, L. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-XL-A potential role in modulating the threshold of cell death. J. Biol. Chem. 274, 24007-24013 (1999).